Latest Scheme Of Arrangement News

Infomedia Ltd’s acquisition by McQueen BidCo, backed by TPG Capital, has been legally approved, triggering trading suspension and scheduled shareholder payments.

Aurumin Limited’s acquisition by Brightstar Resources has been legally approved, triggering a share exchange and imminent delisting from the ASX.

Lynch Group shareholders have overwhelmingly approved the proposed acquisition by Darwin Aus Bidco, clearing a major hurdle ahead of final court approval and trading suspension.

The Supreme Court of New South Wales has approved the acquisition of Infomedia Ltd by a TPG-managed entity, setting a clear path for the scheme’s implementation and a special dividend payout.

Lynch Group Holdings shareholders have overwhelmingly approved a $269 million acquisition scheme by Hasfarm, offering a 23% premium on recent share prices. The deal awaits final court approval before completion in December 2025.

Lynch Group Holdings Limited shareholders convened to vote on a proposed $2.155 per share acquisition by Hasfarm Bidco, with strong board and expert backing. The scheme offers a significant premium and awaits final court approval.

Mayne Pharma’s acquisition by Cosette Pharmaceuticals faces a brief delay as FIRB extends its approval deadline, prompting a reschedule of the critical court hearing to November 23.

Brightstar Resources has received court approval to acquire Aurumin Limited, consolidating the Sandstone Gold Project and boosting its combined mineral resource to 2.4 million ounces. The acquisition positions Brightstar as a rising mid-tier gold producer in Western Australia.

The Supreme Court of Western Australia has approved Brightstar Resources’ acquisition of Aurumin Limited, setting the stage for Aurumin’s shares to be suspended and delisted from the ASX by early December.

The Takeovers Panel has declared unacceptable circumstances in the Mayne Pharma acquisition, ordering Cosette Pharmaceuticals to comply with conditions preventing closure of the Salisbury manufacturing site. This ruling highlights concerns over market transparency and the integrity of the takeover process.

The Takeovers Panel has declared unacceptable circumstances in the Mayne Pharma acquisition after Cosette Pharmaceuticals changed its intentions to close the Salisbury manufacturing site, raising concerns over market transparency and regulatory approval.

Astron Limited has received a pivotal Australian Taxation Office Class Ruling confirming capital gains tax roll-over relief for shareholders following its redomicile from Hong Kong to Australia. This development streamlines the company’s structure and offers potential long-term benefits to investors.